Related Experiment Video

Updated: Aug 16, 2026

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on: May 17, 2024

Vascular dementia and anticardiolipin antibodies

José Maria Pereira de Godoy1, Maria Regina Pereira de Godoy, José Paulo Cipulo

  • 1Department of Cardiology and Vascular Surgery, São José do Rio Preto University School of Medicine, São Paulo, SP, Brazil. godoyjmp@riopreto.com.br

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|August 30, 2005
PubMed

Insights

High levels of anticardiolipin antibodies were found in over half of vascular dementia patients, significantly more than in controls. This suggests anticardiolipin antibodies are a risk factor for vascular dementia.

Area of Science:

  • Neurology
  • Immunology
  • Cardiovascular Research

Background:

  • Recent studies suggest a link between anticardiolipin antibodies and dementia, but the underlying mechanisms are unclear.
  • Vascular dementia is a significant cause of cognitive decline, and identifying its risk factors is crucial.

Purpose of the Study:

  • To investigate the association between anticardiolipin antibodies and vascular dementia.
  • To determine if anticardiolipin antibodies are a risk factor for developing vascular dementia.

Main Methods:

  • A prospective study involving 30 vascular dementia patients (17 male, 13 female) and 34 controls (9 male, 25 female).
  • Vascular dementia was diagnosed using NINDS-AIREN criteria.
  • Anticardiolipin antibodies (IgG and IgM) were quantified using Enzyme-Linked Immunoabsorbent Assay (ELISA).

Main Results:

  • Elevated anticardiolipin antibody levels were present in 56.6% of vascular dementia patients.
  • Only 26.4% of the control group showed elevated anticardiolipin antibody levels.
  • The difference in antibody prevalence between the groups was statistically significant (p<0.02).

Conclusions:

  • A significant association exists between high levels of anticardiolipin antibodies and vascular dementia.
  • Anticardiolipin antibodies are identified as a potential risk factor for vascular dementia.
  • Further research into the physiopathological mechanisms linking these antibodies to dementia is warranted.
Abstract

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...